by Bianca Garilli, ND Non-alcoholic fatty liver disease (NAFLD), characterized by fat accumulation in the liver not caused by alcohol consumption, affects up to 25% of people in the US.1 This is typically a silent disease, often not producing symptoms until its later stages when there is chronic liver injury; complaints can include fatigue, weakness, weight … Continue reading Novel Use for Oral Glutathione: Treatment of Nonalcoholic Fatty Liver Disease